Cargando…
Schizophrenia shows a unique metabolomics signature in plasma
Schizophrenia is a severe complex mental disorder affecting 0.5–1% of the world population. To date, diagnosis of the disease is mainly based on personal and thus subjective interviews. The underlying molecular mechanism of schizophrenia is poorly understood. Using targeted metabolomics we quantifie...
Autores principales: | He, Y, Yu, Z, Giegling, I, Xie, L, Hartmann, A M, Prehn, C, Adamski, J, Kahn, R, Li, Y, Illig, T, Wang-Sattler, R, Rujescu, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432190/ https://www.ncbi.nlm.nih.gov/pubmed/22892715 http://dx.doi.org/10.1038/tp.2012.76 |
Ejemplares similares
-
Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
por: Stratmann, Bernd, et al.
Publicado: (2017) -
Reliability of Serum Metabolite Concentrations over a 4-Month Period Using a Targeted Metabolomic Approach
por: Floegel, Anna, et al.
Publicado: (2011) -
Alcohol-induced metabolomic differences in humans
por: Jaremek, M, et al.
Publicado: (2013) -
A network-based conditional genetic association analysis of the human metabolome
por: Tsepilov, Y A, et al.
Publicado: (2018) -
Metabolomics shows the Australian dingo has a unique plasma profile
por: Yadav, Sonu, et al.
Publicado: (2021)